HDAC-IN-28

• UNSPSC Description:

  HDAC-IN-28, a novel HDAC inhibitor, shows potent activities against tumor growth and metastasis

• Target Antigen:

  HDAC

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/hdac-in-28.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CCCCCC(N(CC1=CC=C(C2=CN=CN=C2)S1)C3=CC=C(C=C3)OC)=O)NO

• Molecular Weight:

  454.54

• References & Citations:

  [1]Yang F, et al. Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis. J Med Chem. 2014 Nov 26;57(22):9357-69.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1621154-88-8